This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Why Should You Hold on to Tenet Healthcare (THC) Stock?
by Zacks Equity Research
Despite the recent drag in Tenet Healthcare's (THC) business volumes, the same is expected to bounce back, given its solid fundamentals and the strategic initiatives taken.
Hospital Industry's Dull Near-Term Outllook Induced by Coronavirus
by Sapna Bagaria
Revenue loss and cost rise due to coronavirus outbreak put hospital companies in a tight spot.
MEDNAX Plunges More Than 42% YTD: Will the Stock Rebound?
by Zacks.com
Even though MEDNAX (MD) endures the COVID-19 impact on global economy, it holds prospects to revive its fortunes with the help of its initiatives and strong fundamentals.
Here's Why You Should Stay Away From HCA Healthcare Now
by Zacks.com
Depressed revenues and elevated expenses make HCA Healthcare (HCA) an unattractive bet.
Why Should You Hold onto Acadia Healthcare Stock?
by Sapna Bagaria
Despite the recent drag in Acadia Healthcare's (ACHC) business volumes, the same is expected to bounce back, given the defensive demand for its mental and behavioral health business.
Ensign Group's (ENSG) Q1 Earnings Beat, Revenues Up Y/Y
by Zacks Equity Research
Ensign Group's (ENSG) first-quarter 2020 results reflect strong revenues courtesy of robust segmental performance, partly offset by high costs.
MEDNAX Divests American Anesthesiology to Avoid Cash Losses
by Zacks Equity Research
MEDNAX (MD) sells its American Anesthesiology to NAPA for portfolio rationalization and averting the negative COVID-19 impact.
MEDNAX's (MD) Earnings Miss Estimates in Q1, Tumble Y/Y
by Zacks Equity Research
MEDNAX's (MD) Q1 results reflect the coronavirus adversities that drained its revenues and volumes.
Tenet Healthcare (THC) Q1 Earnings Beat Estimates, Rise Y/Y
by Zacks Equity Research
Tenet Healthcare's (THC) Q1 results reflect a strong operating performance and an income tax benefit, partly offset by the coronavirus outbreak.
Tenet Healthcare (THC) Q1 Earnings Beat Estimates
by Zacks Equity Research
Tenet (THC) delivered earnings and revenue surprises of 433.33% and -2.25%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Tenet Healthcare (THC) Q1 Earnings Expected to Decline
by Zacks Equity Research
Tenet (THC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Community Health Repeals 2020 Outlook Amid Coronavirus Woes
by Zacks Equity Research
Community Health (CYH) withdraws its current-year guidance amid prevalent market volatility induced by the COVID-19 spread.
Universal Health Plunges 31.4% YTD: Will It Bounce Back?
by Zacks Equity Research
Even though Universal Health (UHS) suffers the COVID-19 impact on global economy, it holds potential to stage a comeback by virtue of its solid fundamentals.
Is the Options Market Predicting a Spike in Tenet Healthcare (THC) Stock?
by Zacks Equity Research
Investors need to pay close attention to Tenet Healthcare (THC) stock based on the movements in the options market lately.
HCA Healthcare, Google Cloud Tie Up Amid Coronavirus Woes
by Zacks Equity Research
HCA Healthcare (HCA) partners Google Cloud and SADA for the COVID-19 National Response Portal, a platform to provide real-time COVID-19 updates.
Select Medical Revokes Full-Year View Amid Coronavirus Blues
by Zacks Equity Research
Plagued by business uncertainty from the coronavirus outbreak, Select Medical (SEM) ditches its 2020 earnings guidance.
Tenet Healthcare (THC) Gets Rating Actions From Moody's
by Zacks Equity Research
Tenet Healthcare (THC) gets specific rating actions from credit rating agency Moody's. The outlook of the ratings is stable.
HCA Healthcare Makes Cost-Control Efforts Amid Coronavirus Woes
by Zacks Equity Research
HCA Healthcare (HCA) trims headcount to contain costs as its revenues are under pressure.
Tenet Heathcare Scraps Q1 & 2020 Guidance Amid Coronavirus Chaos
by Zacks Equity Research
Tenet Heathcare (THC) nullifies its first-quarter and 2020 outlook due to the COVID-19 pandemic.
Tenet Healthcare (THC) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Tenet Healthcare (THC) closed at $13.19 in the latest trading session, marking a +1.38% move from the prior day.
MEDNAX Withdraws Q1 & 2020 Guidance Due to Coronavirus Woes
by Zacks Equity Research
MEDNAX (MD) takes back its first-quarter 2020 and preliminary full-year outlook due to the COVID-19 effect.
Coronavirus-Hit Hospital Stocks Gain on Senate Stimulus Help
by Sapna Bagaria
The stimulus bill will offer the much-required financial relief to COVID-19-plagued hospitals and lead to their share price appreciation.
Why Is Tenet (THC) Down 48.6% Since Last Earnings Report?
by Zacks Equity Research
Tenet (THC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Acadia Healthcare Cancels U.K. Unit Sale on Coronavirus Crisis
by Zacks Equity Research
Acadia Healthcare (ACHC) dismisses plan to sell its U.K. business due to the economic uncertainty caused by coronavirus outbreak.
Brookdale Scraps Earnings View Due to COVID-19 Uncertainty
by Zacks Equity Research
Brookdale (BKD) pulls down 2020 earnings guidance, takes steps to preserve liquidity and incurs additional cost for prevention measures.